These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8975904)

  • 1. Evidence of the proinflammatory role of Enterococcus faecalis in polymicrobial peritonitis in rats.
    Montravers P; Mohler J; Saint Julien L; Carbon C
    Infect Immun; 1997 Jan; 65(1):144-9. PubMed ID: 8975904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of the potential role of Enterococcus faecalis in the pathophysiology of experimental peritonitis.
    Montravers P; Andremont A; Massias L; Carbon C
    J Infect Dis; 1994 Apr; 169(4):821-30. PubMed ID: 8133097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic effects of cefozopran on polymicrobial infections associated with Enterococcus faecalis in a Rat pyometra model.
    Mikamo H; Kawazoe K; Sato Y; Izumi K; Tamaya T
    Chemotherapy; 1998; 44(2):103-7. PubMed ID: 9551240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbiological and inflammatory effects of murine recombinant interleukin-10 in two models of polymicrobial peritonitis in rats.
    Montravers P; Maulin L; Mohler J; Carbon C
    Infect Immun; 1999 Apr; 67(4):1579-84. PubMed ID: 10084989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenicity of enterococci in a rat model of fecal peritonitis.
    Matlow AG; Bohnen JM; Nohr C; Christou N; Meakins J
    J Infect Dis; 1989 Jul; 160(1):142-5. PubMed ID: 2543707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of elements containing glycopeptide resistance genes on expression of virulence in Enterococcus faecalis peritonitis: a pilot study with rats.
    Plantefeve G; Dupont H; Hubert V; Garry L; Poüs C; Carbon C; Montravers P
    Antimicrob Agents Chemother; 2003 May; 47(5):1560-4. PubMed ID: 12709322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disparate findings on the role of virulence factors of Enterococcus faecalis in mouse and rat models of peritonitis.
    Dupont H; Montravers P; Mohler J; Carbon C
    Infect Immun; 1998 Jun; 66(6):2570-5. PubMed ID: 9596718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reciprocal synergy between Escherichia coli and Bacteroides fragilis in an intra-abdominal infection model.
    Rotstein OD; Kao J; Houston K
    J Med Microbiol; 1989 Aug; 29(4):269-76. PubMed ID: 2668529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Escherichia coli and Bacteroides fragilis on peritoneal host defenses.
    Dunn DL; Barke RA; Ewald DC; Simmons RL
    Infect Immun; 1985 May; 48(2):287-91. PubMed ID: 3886544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbial synergy in experimental intra-abdominal abscess.
    Onderdonk AB; Bartlett JG; Louie T; Sullivan-Seigler N; Gorbach SL
    Infect Immun; 1976 Jan; 13(1):22-6. PubMed ID: 814099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A peritonitis model with low mortality and persisting intra-abdominal abscesses.
    Buyne OR; Bleichrodt RP; Verweij PE; Groenewoud HM; van Goor H; Hendriks T
    Int J Exp Pathol; 2006 Oct; 87(5):361-8. PubMed ID: 16965563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial synergism between the enterococcus and Escherichia coli.
    Fry DE; Berberich S; Garrison RN
    J Surg Res; 1985 May; 38(5):475-8. PubMed ID: 3921765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early bacterial and inflammatory responses to antibiotic therapy in a model of polymicrobial peritonitis in rats.
    Montravers P; Mohler J; Maulin L; Carbon C
    Clin Microbiol Infect; 1998 Feb; 4(12):701-709. PubMed ID: 11864278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergy of Bacteroides fragilis and Escherichia coli in the induction of KC gene expression in mouse peritoneal tissues.
    Kim JM; Kim YJ; Cho YJ
    Scand J Infect Dis; 2000; 32(6):643-9. PubMed ID: 11200375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The kinetics of peritoneal clearance of Escherichia coli and Bacteroides fragilis and participating defense mechanisms.
    Skau T; Nyström PO; Ohman L; Stendahl O
    Arch Surg; 1986 Sep; 121(9):1033-9. PubMed ID: 3527110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The spectrum of Escherichia coli--Bacteroides fragilis pathogenic synergy in an intraabdominal infection model.
    Rotstein OD; Kao J
    Can J Microbiol; 1988 Mar; 34(3):352-7. PubMed ID: 3046726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative efficacies of daptomycin, vancomycin, and linezolid in experimental enterococcal peritonitis.
    Kajihara T; Nakamura S; Iwanaga N; Oshima K; Hirano K; Miyazaki T; Izumikawa K; Yanagihara K; Miyazaki Y; Hattori N; Kohno N; Kohno S; Mukae H
    J Infect Chemother; 2017 Jul; 23(7):498-501. PubMed ID: 28108098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of Escherichia coli alpha-hemolysin to bacterial virulence and to intraperitoneal alterations in peritonitis.
    May AK; Gleason TG; Sawyer RG; Pruett TL
    Infect Immun; 2000 Jan; 68(1):176-83. PubMed ID: 10603385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elimination patterns of Escherichia coli and bacteroides fragilis from the peritoneal cavity. Studies with experimental peritonitis in pigs.
    Nyström PO; Skau T
    Acta Chir Scand; 1983; 149(4):383-8. PubMed ID: 6351520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of TLR/MyD88/MAPK/NF-κB Signaling Pathways in the Regulation of Phagocytosis and Proinflammatory Cytokine Expression in Response to E. faecalis Infection.
    Zou J; Shankar N
    PLoS One; 2015; 10(8):e0136947. PubMed ID: 26317438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.